Journal list menu
Export Citations
Download PDFs
Issue Information
Images in Haematology
no
Acute promyelocytic leukaemia with marked symptomatic hyperleucocytosis
- Page: 649
- First Published: 20 June 2019
no
Acetabular myeloid sarcoma as an extramedullary presentation of chronic myeloid leukaemia blast crisis
- Page: 650
- First Published: 06 June 2019
Editorial Comments
no
Photodepletion – shedding light on allograft reactions
- Pages: 651-652
- First Published: 21 August 2019
no
Towards a better understanding of monoclonal gammopathy of renal significance
- Pages: 653-654
- First Published: 28 May 2019
Reviews
no
The long and winding road to pathogen reduction of platelets, red blood cells and whole blood
- Pages: 655-667
- First Published: 14 July 2019
no
Molecular pathogenesis of chronic lymphocytic leukaemia
- Pages: 668-684
- First Published: 31 July 2019
Haematological Malignancy
no
Raman imaging highlights biochemical heterogeneity of human eosinophils versus human eosinophilic leukaemia cell line
- Pages: 685-694
- First Published: 28 May 2019
no
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients
- Pages: 695-705
- First Published: 22 May 2019
no
Long term outcomes in monoclonal gammopathy of renal significance
- Pages: 706-716
- First Published: 29 May 2019
Free Access
free
Requirement for etoposide in the initial treatment of Epstein-Barr virus–associated haemophagocytic lymphohistiocytosis
- Pages: 717-723
- First Published: 22 May 2019
no
Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies
- Pages: 724-734
- First Published: 24 May 2019
Short Reports
no
Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia
- Pages: 735-740
- First Published: 23 May 2019
Paediatric
no
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)
- Pages: 741-753
- First Published: 24 May 2019
Transplantation
Open Access
oa
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis
- Pages: 754-766
- First Published: 28 May 2019
no
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
- Pages: 767-776
- First Published: 22 May 2019
Short Reports
no
Fatigue and cognitive impairment in immune thrombocytopenic purpura remain stable over time: short report from a longitudinal study
- Pages: 777-781
- First Published: 23 May 2019
Correspondence
Free Access
free
Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al
- Pages: 782-783
- First Published: 08 May 2019
Free Access
free
Type 2 diabetes in adults with sickle cell disease: can we dive deeper?
- Pages: 783-785
- First Published: 08 May 2019
Free Access
free
Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots
- Pages: 785-788
- First Published: 14 May 2019
Free Access
free
NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology – response to Lester et al
- Pages: 788-789
- First Published: 31 May 2019
Free Access
free
NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology
- Pages: 790-791
- First Published: 05 June 2019
Free Access
free
The National VTE Exemplar Centres Network response to implementation of updated NICE guidance: venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)
- Pages: 792-793
- First Published: 05 June 2019
Free Access
free
Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study
- Pages: e117-e121
- First Published: 15 May 2019
Free Access
free
Longitudinal trend analysis of serum transferrin receptor-1 level in a cohort of patients affected by non-transfusion dependent thalassaemia
- Pages: e121-e123
- First Published: 07 May 2019
Free Access
free
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)
- Pages: e123-e126
- First Published: 20 May 2019
Free Access
free
Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group
- Pages: e126-e130
- First Published: 22 May 2019
Free Access
free
Impact of ruxolitinib on myelofibrosis patients post allogeneic stem cell transplant—a pilot study
- Pages: e130-e133
- First Published: 22 May 2019
Free Access
free
Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents
- Pages: e133-e137
- First Published: 28 May 2019
Free Access
free
Utility of fibrinogen in the coagulation screen
- Pages: e137-e139
- First Published: 16 May 2019
Free Access
free
Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant
- Pages: e139-e141
- First Published: 21 May 2019
Free Access
free
A nonsense variant in the Hexokinase 1 gene (HK1) causing severe non-spherocytic haemolytic anaemia: genetic analysis exemplifies ambiguity due to multiple Isoforms
- Pages: e142-e145
- First Published: 23 May 2019
Free Access
free
Arsenic trioxide suppresses acute graft-versus-host disease by activating the Nrf2/HO-1 pathway in mice
- Pages: e145-e148
- First Published: 28 May 2019
Free Access
free
Direct oral anticoagulants for the management of venous thromboembolism in patients with HIV – a single centre experience
- Pages: e148-e151
- First Published: 05 June 2019
Free Access
free
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome
- Pages: e151-e155
- First Published: 09 June 2019
Free Access
free
Large deletions of the 5′ region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia
- Pages: e155-e159
- First Published: 30 May 2019
Free Access
free
Hereditary elliptocytosis with variable expression and incomplete penetrance in a Chinese family
- Pages: e159-e162
- First Published: 05 June 2019